FAVAX
Price
$23.24
Change
+$0.31 (+1.35%)
Updated
May 2 closing price
Net Assets
204.38M
VIVIX
Price
$65.79
Change
+$1.00 (+1.54%)
Updated
May 2 closing price
Net Assets
190.51B
Ad is loading...

FAVAX vs VIVIX

Header iconFAVAX vs VIVIX Comparison
Open Charts FAVAX vs VIVIXBanner chart's image
Fidelity Advisor Equity Value A
Price$23.24
Change+$0.31 (+1.35%)
VolumeN/A
Net Assets204.38M
Vanguard Value Index I
Price$65.79
Change+$1.00 (+1.54%)
VolumeN/A
Net Assets190.51B
FAVAX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAVAX vs. VIVIX commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAVAX is a Buy and VIVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 191B vs. FAVAX (204M). VIVIX pays higher dividends than FAVAX: VIVIX (2.35) vs FAVAX (1.61). FAVAX was incepted earlier than VIVIX: FAVAX (24 years) vs VIVIX (27 years). FAVAX (0.93) is less costly to investors than VIVIX (0.04). FAVAX is a more actively managed with annual turnover of: 31.00 vs. VIVIX (9.00). FAVAX has a lower initial minimum investment than VIVIX: FAVAX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.67 vs. FAVAX (2.43). VIVIX return over 5 years is better than : 76.44 vs. FAVAX (66.13).
FAVAXVIVIXFAVAX / VIVIX
Total Expense Ratio0.930.042,325%
Annual Report Gross Expense Ratio0.930.042,325%
Fund Existence24 years27 years-
Gain YTD0.737-0.336-220%
Front Load6%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets204M191B0%
Annual Yield % from dividends1.612.3568%
Returns for 1 year2.437.6732%
Returns for 3 years7.5119.0539%
Returns for 5 years66.1376.4487%
Returns for 10 years48.8098.8449%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.500.06
+14.71%
AEON Biopharma
CASS41.600.30
+0.73%
Cass Information Systems
AVTE93.80N/A
N/A
Aerovate Therapeutics
INSM72.30-0.34
-0.47%
Insmed
CGEN1.48-0.04
-2.63%
Compugen Ltd